The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The Global Challenge of Carbapenem-Resistant Enterobacteriaceae in Transplant Recipients and Patients With Hematologic Malignancies
Open accessAbstract
Carbapenem-resistant Enterobacteriaceae (CRE) are emerging global pathogens. The spread of CRE to transplant recipients and patients with hematologic malignancies has ominous implications. These patients rely on timely, active antibacterial therapy to combat gram-negative infections; however, recommended empirical regimens are not active against CRE. Approximately 3%-10% of solid organ transplant (SOT) recipients in CRE-endemic areas develop CRE infection, and the infection site correlates with the transplanted organ. Mortality rates associated with CRE infections approach 40% in SOT recipients and 65% in patients with hematologic malignancies. Given that the current antimicrobial armamentarium to combat CRE is extremely limited, a multifaceted approach that includes antimicrobial stewardship and active surveillance is needed to prevent CRE infections in immunocompromised hosts. Improving outcomes of established infections will require the use of risk factor-based prediction tools and molecular assays to more rapidly administer CRE-active therapy and the development of new antimicrobial agents with activity against CRE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Self-citationSystem, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Program, N. C. S., Henderson, D. K., Palmore, T. N., & Segre, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004129 · Cited by 863
Patel, G., Huprikar, S., Factor, S. H., Jenkins, S. G., & Calfee, D. P. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/592412 · Cited by 836
Self-citationBoucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E., Polsky, B., Adams-Haduch, J. M., & Doi, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06268-11 · Cited by 559
Schwaber, M. J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., Shalit, I., Carmeli, Y., & the Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir025 · Cited by 453
Zarkotou, O., Pournaras, S., Tselioti, P., Dragoumanos, V., Pitiriga, V., Ranellou, K., Prekates, A., Themeli-Digalaki, K., & Tsakris, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03514.x · Cited by 438
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
Zhanel, G. G., Lawson, C. D., Adam, H., Schweizer, F., Zelenitsky, S., Lagacé-Wiens, P. R. S., Denisuik, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2013) · Drugs · doi:10.1007/s40265-013-0013-7 · Cited by 433
Sandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Pogue, J. M., Lee, J., Marchaim, D., Yee, V., Zhao, J. J., Chopra, T., Lephart, P., & Kaye, K. S. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir611 · Cited by 327
Gales, A. C., Castanheira, M., Jones, R. N., & Sader, H. S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.04.007 · Cited by 318
Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., & Landman, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki175 · Cited by 307
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Prasad, P., Sun, J., Danner, R. L., & Natanson, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis270 · Cited by 298
Hindler, J. A., & Humphries, R. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03385-12 · Cited by 241
Lucasti, C., Popescu, I., Ramesh, M. K., Lipka, J., & Sable, C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks523 · Cited by 234
PHARMACOKINETICS AND PHARMACODYNAMICS
HULL, C. J. (1979) · British Journal of Anaesthesia · doi:10.1093/bja/51.7.579 · Cited by 229
Karageorgopoulos, D. E., Wang, R., Yu, X.-H., & Falagas, M. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr466 · Cited by 228
Vazquez, J. A., González Patzán, L. D., Stricklin, D., Duttaroy, D. D., Kreidly, Z., Lipka, J., & Sable, C. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.748653 · Cited by 219
Endimiani, A., Hujer, A. M., Perez, F., Bethel, C. R., Hujer, K. M., Kroeger, J., Oethinger, M., Paterson, D. L., Adams, M. D., Jacobs, M. R., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn547 · Cited by 216
Self-citationHussein, K., Sprecher, H., Mashiach, T., Oren, I., Kassis, I., & Finkelstein, R. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/598244 · Cited by 215
Lu, Q., Yang, J., Liu, Z., Gutierrez, C., Aymard, G., Rouby, J.-J., & the Nebulized Antibiotics Study Group (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1894oc · Cited by 214
Blaschke, A. J., Heyrend, C., Byington, C. L., Fisher, M. A., Barker, E., Garrone, N. F., Thatcher, S. A., Pavia, A. T., Barney, T., Alger, G. D., et al. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.08.013 · Cited by 209
Kofteridis, D. P., Alexopoulou, C., Valachis, A., Maraki, S., Dimopoulou, D., Georgopoulos, D., & Samonis, G. (2010) · Clinical Infectious Diseases · doi:10.1086/657242 · Cited by 207
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Bulik, C. C., & Nicolau, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01420-10 · Cited by 200
Marchaim, D., Navon-Venezia, S., Schwaber, M. J., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-07 · Cited by 195
Kochar, S., Sheard, T., Sharma, R., Hui, A., Tolentino, E., Allen, G., Landman, D., Bratu, S., Augenbraun, M., & Quale, J. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/596734 · Cited by 191
Tumbarello, M., De Pascale, G., Trecarichi, E. M., De Martino, S., Bello, G., Maviglia, R., Spanu, T., & Antonelli, M. (2013) · Chest · doi:10.1378/chest.13-1018 · Cited by 182
Schechner, V., Kotlovsky, T., Kazma, M., Mishali, H., Schwartz, D., Navon-Venezia, S., Schwaber, M. J., & Carmeli, Y. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03888.x · Cited by 180
Munoz-Price, L. S., Hayden, M. K., Lolans, K., Won, S., Calvert, K., Lin, M., Sterner, A., & Weinstein, R. A. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651097 · Cited by 167
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
Bergen, P. J., Landersdorfer, C. B., Zhang, J., Zhao, M., Lee, H. J., Nation, R. L., & Li, J. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.07.010 · Cited by 162
Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy
Kubin, C. J., Ellman, T. M., Phadke, V., Haynes, L. J., Calfee, D. P., & Yin, M. T. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.01.015 · Cited by 158
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
Meletis, G., Tzampaz, E., Sianou, E., Tzavaras, I., & Sofianou, D. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr007 · Cited by 154
Bergamasco, M. D., Barbosa, M. B., Garcia, D. D. O., Cipullo, R., Moreira, J. C. M., Baía, C. E. S., Barbosa, V. S. A., & Abboud, C. S. (2011) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00688.x · Cited by 153
Panidis, D., Markantonis, S. L., Boutzouka, E. G., Karatzas, S., & Baltopoulos, G. I. (2005) · CHEST Journal · doi:10.1378/chest.128.2.545 · Cited by 153
New Delhi Metallo-β-Lactamase–producingEnterobacteriaceae, United States
Rasheed, J. K., Kitchel, B., Zhu, W., Anderson, K. F., Clark, N. C., Ferraro, M. J., Savard, P., Humphries, R. M., Kallen, A. J., & Limbago, B. M. (2013) · Emerging infectious diseases · doi:10.3201/eid1906.121515 · Cited by 145
Calfee, D. P., & Jenkins, S. G. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/590661 · Cited by 141
Self-citationLübbert, C., Becker-Rux, D., Rodloff, A. C., Laudi, S., Busch, T., Bartels, M., & Kaisers, U. X. (2013) · Infection · doi:10.1007/s15010-013-0547-3 · Cited by 134
Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin
Tan, T. Y., & Ng, S. Y. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01708.x · Cited by 126
Satlin, M. J., Calfee, D. P., Chen, L., Fauntleroy, K. A., Wilson, S. J., Jenkins, S. G., Feldman, E. J., Roboz, G. J., Shore, T. B., HELFGOTT, D. C., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.723210 · Cited by 126
Self-citationGiamarellou, H., Galani, L., Baziaka, F., & Karaiskos, I. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02399-12 · Cited by 125
Clancy, C. J., Chen, L., Shields, R. K., Zhao, Y., Cheng, S., Chavda, K. D., Hao, B., Hong, J. H., Doi, Y., Kwak, E. J., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12424 · Cited by 112
Ceccarelli, G., Falcone, M., Giordano, A., Mezzatesta, M. L., Caio, C., Stefani, S., & Venditti, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00188-13 · Cited by 88
Zuckerman, T., Benyamini, N., Sprecher, H., Fineman, R., Finkelstein, R., Rowe, J. M., & Oren, I. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.279 · Cited by 80
Fatal cross infection by carbapenem‐resistant Klebsiella in two liver transplant recipients
Mathers, A. J., Cox, H. L., Bonatti, H., Kitchel, B., Brassinga, A. K. C., Wispelwey, B., Sawyer, R. G., Pruett, T. L., Hazen, K. C., Patel, J. B., et al. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00374.x · Cited by 78
Chen, S., Hu, F., Xu, X., Liu, Y., Wu, W., Zhu, D., & Wang, H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00047-11 · Cited by 60
“Nightmare” Bacteria on the Rise in US Hospitals, Long-term Care Facilities
Kuehn, B. M. (2013) · JAMA · doi:10.1001/jama.2013.2922 · Cited by 53
Satlin, M. J., Jenkins, S. G., Chen, L., HELFGOTT, D. C., Feldman, E. J., Kreiswirth, B. N., & Schuetz, A. N. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00004-13 · Cited by 25
Self-citationZuckerman, T., Benyamini, N., Sprecher, H., Fineman, R., Finkelstein, R., Rowe, J. M., & Oren, I. (2010) · Cited by 19
Cited by
Kadri, S. S., Adjemian, J., Lai, Y. L., Spaulding, A. B., Ricotta, E., Prevots, D. R., Palmore, T. N., Rhee, C., Klompas, M., Dekker, J. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy378 · Cited by 605
The rapid spread of carbapenem-resistant Enterobacteriaceae
Potter, R. F., D’Souza, A. W., & Dantas, G. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.002 · Cited by 403
Treating infections caused by carbapenemase-producing Enterobacteriaceae
Tzouvelekis, L. S., Markogiannakis, A., Piperaki, E., Souli, M., & Daikos, G. L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12697 · Cited by 337
The European Hematology Association Roadmap for European Hematology Research: a consensus document
Engert, A., Balduini, C., Brand, A., Coiffier, B., Cordonnier, C., Dohner, H., de Wit, T. D., Eichinger, S., Fibbe, W., Green, T., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136739 · Cited by 81
Metadata
- Authors
- Satlin, M. J., Jenkins, S. G., & Walsh, T. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-23
- Volume
- 58
- Issue
- 9
- Pages
- 1274-1283
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2114237392
- Cited by
- 255
- References
- 60
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.